A randomized, double-blind, placebo-controlled trial to investigate immune responses elicited by a liquid formulation of influenza virus vaccine, trivalent types A and B, live cold adapted (CAIV-T) [influenza virus vaccine live] in healthy adults aged 18 and older
Phase of Trial: Phase III
Latest Information Update: 31 Oct 2006
At a glance
- Drugs Influenza virus vaccine live (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors MedImmune
- 31 Oct 2006 Status change
- 31 Oct 2006 The expected completion date for this trial is now .
- 12 Dec 2005 New trial record.